ABSTRACT
Aims Numerous diagnostic criteria for excessive trabeculation (ET), or so-called “noncompaction”, score the extent of the trabecular layer, yet whether the trabeculations themselves have a negative or positive impact on pump function is largely unknown. This study aimed to measure the ejection fraction (EF) of the trabecular layer and its impact on pump function assessment.
Methods and results We retrospectively analyzed cardiac magnetic resonance (CMR) findings in patients with ET of the left ventricle (LV). The LV was labelled into four regions: compact wall, central cavity (CC), trabeculations, and intertrabecular recesses (IR). For each label we calculated the systolic fractional volume change (SFVC) in short-axis images (n=15) and systolic fractional area change (SFAC) in 4-chamber images (n=30), by dividing end-systolic to end-diastolic values. We measured the EF of IR, CC, and total cavity (TC). Three methods to calculate EF of the TC were compared: trabeculations included (per guidelines), IR excluded (Jacquier criterion), trabeculations contoured and excluded (contour-EF).
The SFVC and SFAC of the compact wall were similar with SFVC and SFAC of trabeculations (both P>0.05). In contrast, the IR were more diminished in systole by comparison with the CC, having lower SFVC (39±17% vs. 56±16%, P<0.001) and SFAC (37±22% vs. 72±12%, P<0.001). EF of the IR was also greater than EF of the CC (61±17% vs. 44±16%, P<0.001). Excluding IR from the TC or including trabeculations underestimates the contour-EF (44±16% and 40±12%, respectively, vs. 51±16%; both P<0.001).
Conclusions The trabecular layer has a high EF. Values of key prognostic indicators are better when this is accounted for.
Graphical AbstractEF, ejection fraction; LVEF, left ventricular ejection fraction; SAX, short-axis; 4c, 4 chamber. *P<0001
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was partly funded by a National Grant of the Romanian Ministry of Research and Innovation: project No. PN-III-P1-1.1-TE-2016-0669.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the University and Emergency Hospital (Bucharest, Romania) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the corresponding author.
